Joseph P. Hagan

Sr. VP, Corporate Development, Orexigen Therapeutics, Inc.

Companies

Regulus Therapeutics Inc.Board member May 8, 2017 to now¹
Regulus Therapeutics Inc.Chief executive officer May 8, 2017 to now¹
Regulus Therapeutics Inc.President May 8, 2017 to Aug 14, 2023¹
Aurinia Pharmaceuticals Inc.Board member Jun 16, 2021 to May 23, 2023²
Zosano Pharma CorpBoard member May 27, 2015 to Jun 14, 2021³
Regulus Therapeutics Inc.Chief operating officer Jan 6, 2016 to Feb 23, 2017⁴

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 25, 2025Returned to company 571,558 shares of Regulus Therapeutics Inc.⁶
Jan 30, 2025Bought 50,000 shares at $1.09 of Regulus Therapeutics Inc.⁷
Jan 14, 2025Sold 11,764 shares at $1.26 of Regulus Therapeutics Inc.⁸
Jan 13, 2025Sold 115,290 shares at $1.26 of Regulus Therapeutics Inc.⁸
Jan 9, 2025Granted 62,000 shares at $1.30 of Regulus Therapeutics Inc.⁹
Jan 9, 2025Granted 218,750 shares at $1.36 of Regulus Therapeutics Inc.⁹
Jan 18, 2024Sold 14,580 shares at $1.19 of Regulus Therapeutics Inc.¹⁰
Jan 12, 2024Granted 30,000 shares of Regulus Therapeutics Inc.¹¹
May 19, 2023Sold 272 shares at $10.58 of Aurinia Pharmaceuticals Inc.⁵
May 18, 2023Exercised options 8,733 shares of Aurinia Pharmaceuticals Inc.⁵
Jan 26, 2022Bought 100,000 shares at $0.22 of Regulus Therapeutics Inc.¹²
Jan 3, 2022Sold 634 shares at $23.29 of Aurinia Pharmaceuticals Inc.¹³
Jan 3, 2022Sold 39,366 shares at $22.58 of Aurinia Pharmaceuticals Inc.¹³
Jan 3, 2022Exercised options 40,000 shares at $5.08 of Aurinia Pharmaceuticals Inc.¹³

The numbers on this page point here. Each one links to the record it came from.